Status:
RECRUITING
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
Lead Sponsor:
UNICANCER
Collaborating Sponsors:
Roche Pharma AG
Pierre Fabre Laboratories
Conditions:
Metastatic Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The Epidemiological Strategy and Medical Economic (ESME) Breast cancer Database is a multicenter real life database using a retrospective data collection process across 18 French comprehensive cancer ...
Detailed Description
This database compiles existing data retrieved fromp patient's electronic medical records (EMR) across the 18 French comprehensive cancer centers spread over 20 sites. . The database includes data re...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- 18 years old patient
- Patient receiving chemotherapy, targeted therapy, immunotherapy, radiation therapy and hormonotherapy in a French Comprehensive Cancer Center.
- Exclusion criteria : None
Exclusion
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
40000 Patients enrolled
Trial Details
Trial ID
NCT03275311
Start Date
July 1 2014
End Date
December 1 2026
Last Update
April 25 2025
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancérologie de l'Ouest - Paul Papin
Angers, France, 49933
2
Institut Bergonié
Bordeaux, France, 33076
3
Centre François Baclesse
Caen, France, 14076
4
Centre Jean Perrin
Clermont-Ferrand, France, 63011